USD 0.75
(3.79%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 5.06 Million USD | -36.38% |
2022 | 7.95 Million USD | 27.75% |
2021 | 6.22 Million USD | 171.61% |
2020 | 2.29 Million USD | 62.16% |
2019 | 1.41 Million USD | 2.69% |
2018 | 1.37 Million USD | 16.3% |
2017 | 1.18 Million USD | 33.33% |
2016 | 888 Thousand USD | 47.75% |
2015 | 601 Thousand USD | 156.84% |
2014 | 234 Thousand USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 5.13 Million USD | 4.41% |
2024 Q1 | 4.91 Million USD | -2.88% |
2023 Q4 | 5.06 Million USD | -7.48% |
2023 FY | 5.06 Million USD | -36.38% |
2023 Q1 | 6.87 Million USD | -13.56% |
2023 Q3 | 5.47 Million USD | -7.49% |
2023 Q2 | 5.91 Million USD | -14.0% |
2022 Q2 | 8.34 Million USD | 7.25% |
2022 Q3 | 7.76 Million USD | -7.01% |
2022 Q4 | 7.95 Million USD | 2.5% |
2022 FY | 7.95 Million USD | 27.75% |
2022 Q1 | 7.78 Million USD | 24.97% |
2021 Q3 | 4.05 Million USD | -11.3% |
2021 Q1 | 5.02 Million USD | 118.93% |
2021 Q4 | 6.22 Million USD | 53.47% |
2021 Q2 | 4.57 Million USD | -8.86% |
2021 FY | 6.22 Million USD | 171.61% |
2020 FY | 2.29 Million USD | 62.16% |
2020 Q1 | 1.22 Million USD | -13.65% |
2020 Q2 | 1.34 Million USD | 9.83% |
2020 Q3 | 1.57 Million USD | 17.23% |
2020 Q4 | 2.29 Million USD | 45.87% |
2019 Q2 | 1.81 Million USD | -5.46% |
2019 FY | 1.41 Million USD | 2.69% |
2019 Q3 | 1.47 Million USD | -19.02% |
2019 Q4 | 1.41 Million USD | -4.01% |
2019 Q1 | 1.92 Million USD | 39.72% |
2018 Q2 | 1.16 Million USD | 28.07% |
2018 Q1 | 912 Thousand USD | -22.97% |
2018 FY | 1.37 Million USD | 16.3% |
2018 Q4 | 1.37 Million USD | 35.0% |
2018 Q3 | 1.02 Million USD | -12.67% |
2017 Q4 | 1.18 Million USD | 28.14% |
2017 FY | 1.18 Million USD | 33.33% |
2017 Q1 | 849 Thousand USD | -4.39% |
2017 Q2 | 717 Thousand USD | -15.55% |
2017 Q3 | 924 Thousand USD | 28.87% |
2016 Q3 | 1.11 Million USD | 10.58% |
2016 Q4 | 888 Thousand USD | -20.57% |
2016 FY | 888 Thousand USD | 47.75% |
2016 Q2 | 1.01 Million USD | 0.6% |
2016 Q1 | 1 Million USD | 67.22% |
2015 FY | 601 Thousand USD | 156.84% |
2015 Q4 | 601 Thousand USD | 90.79% |
2015 Q3 | 315 Thousand USD | 52.17% |
2015 Q2 | 207 Thousand USD | -10.39% |
2015 Q1 | 231 Thousand USD | -1.28% |
2014 Q1 | - USD | 0.0% |
2014 FY | 234 Thousand USD | 0.0% |
2014 Q4 | 234 Thousand USD | 114.68% |
2014 Q3 | 109 Thousand USD | 395.45% |
2014 Q2 | 22 Thousand USD | 0.0% |
2013 Q2 | -654.3 Thousand USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q3 | - USD | 100.0% |
2013 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aclaris Therapeutics, Inc. | - USD | -Infinity% |
Applied DNA Sciences, Inc. | 330.02 Thousand USD | -1433.814% |
Aspira Women's Health Inc. | 227 Thousand USD | -2129.956% |
Biodesix, Inc. | 1.4 Million USD | -261.571% |
BioNexus Gene Lab Corp. | 1.13 Million USD | -344.905% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -27285.847% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -27285.847% |
Bionano Genomics, Inc. | 22.89 Million USD | 77.888% |
CareDx, Inc | 19.47 Million USD | 74.002% |
Check-Cap Ltd. | - USD | -Infinity% |
Castle Biosciences, Inc. | 7.94 Million USD | 36.263% |
Exact Sciences Corporation | 127.47 Million USD | 96.029% |
Fulgent Genetics, Inc. | 5.82 Million USD | 13.129% |
Guardant Health, Inc. | 61.94 Million USD | 91.829% |
ICON Public Limited Company | 1.00 USD | -506199900.0% |
IDEXX Laboratories, Inc. | 380.28 Million USD | 98.669% |
Illumina, Inc. | 587 Million USD | 99.138% |
Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -551.03% |
iSpecimen Inc. | - USD | -Infinity% |
Standard BioTools Inc. | 20.53 Million USD | 75.347% |
MDxHealth SA | 2.77 Million USD | -82.152% |
23andMe Holding Co. | 12.46 Million USD | 59.39% |
Medpace Holdings, Inc. | 1.00 USD | -506199900.0% |
Myriad Genetics, Inc. | 20.1 Million USD | 74.816% |
Mainz Biomed B.V. | 613.63 Thousand USD | -724.916% |
ENDRA Life Sciences Inc. | 2.62 Million USD | -92.995% |
NeoGenomics, Inc. | 24.15 Million USD | 79.045% |
Neogen Corporation | 189.26 Million USD | 97.325% |
Inotiv, Inc. | 56.1 Million USD | 90.977% |
Natera, Inc. | 40.75 Million USD | 87.581% |
OPKO Health, Inc. | 65.69 Million USD | 92.295% |
Psychemedics Corporation | 1.00 USD | -506199900.0% |
Prenetics Global Limited | 3.12 Million USD | -61.892% |
Prenetics Global Limited | 3.12 Million USD | -61.892% |
Precipio, Inc. | 384 Thousand USD | -1218.229% |
Personalis, Inc. | 5.66 Million USD | 10.581% |
RadNet, Inc. | 1.00 USD | -506199900.0% |
Sera Prognostics, Inc. | - USD | -Infinity% |
Sotera Health Company | 51.98 Million USD | 90.263% |
Neuronetics, Inc. | 8.09 Million USD | 37.452% |
Star Equity Holdings, Inc. | 3.42 Million USD | -48.012% |
Star Equity Holdings, Inc. | 3.42 Million USD | -48.012% |
Trinity Biotech plc | 19.93 Million USD | 74.605% |
Twist Bioscience Corporation | 32.06 Million USD | 84.212% |
Exagen Inc. | 2.87 Million USD | -76.315% |